epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Isovue

iopamidol

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Risk with Inadvertent Intrathecal Administration

inadvertent intrathecal administration may cause death, convulsions, seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, rhabdomyolysis, hyperthermia, and brain edema; for intra-arterial or IV use only

Adult Dosing .

Dosage forms:  INJ: 200 mg per mL, 250 mg per mL, 300 mg per mL, 370 mg per mL

Special Note

[strength clarification]
Info: strength expressed as iodine concentration
[equivalency or interchangeability info]
Info: not interchangeable with intrathecal iopamidol products; do not substitute on a mg to mg basis

angiocardiography

[selective coronary artery]
Dose: 2-10 mL (370 mg per mL) intra-arterially x1; Max: cumulative dose 200 mL
[nonselective coronary arteries]
Dose: 25-50 mL (370 mg per mL) intra-arterially x1; Max: cumulative dose 200 mL
[ventricle]
Dose: 25-50 mL (370 mg per mL) intra-arterially x1; Max: cumulative dose 200 mL

aortography and selective visceral arteriography

[aortic arch or celiac artery]
Dose: up to 50 mL (370 mg per mL) intra-arterially x1; Max: cumulative dose 225 mL
[renal arteries]
Dose: up to 10 mL (370 mg per mL) intra-arterially x1; Max: cumulative dose 225 mL

cerebral arteriography

[8-12 mL (300 mg per mL) intra-arterially x1]
Max: cumulative dose 90 mL

peripheral arteriography

[subclavian or femoral artery]
Dose: 5-40 mL (300 mg per mL) intra-arterially x1; Max: cumulative dose 250 mL
[aorta distal runoff]
Dose: 25-50 mL (300 mg per mL) intra-arterially x1; Max: cumulative dose 250 mL

computed tomography

[head]
Dose: 130-240 mL (250 mg per mL) IV x1: Alt: 100-200 mL (300 mg per mL) IV x1
[body]
Dose: 130-240 mL (250 mg per mL) IV x1: Alt: 100-200 mL (300 mg per mL) IV x1; 80-160 mL (370 mg per mL) IV x1
[abdomen or pelvis]
Dose: 500-1000 mL (6 mg per mL or 9 mg per mL) PO x1; Start: 60min before procedure; Info: dilute 200 mg per mL, 250 mg per mL, 300 mg per mL, or 370 mg per mL INJ solution for PO use, see pkg insert

excretory urography

[50-100 mL (250 mg per mL) IV x1]
Alt: 50 mL (300 mg per mL) IV x1; 40 mL (370 mg per mL) IV x1

peripheral venography

[25-150 mL (200 mg per mL) IV x1 per leg]
Max: 350 mL/total dose; Alt: 15-100 mL (300 mg per mL) IV x1 per leg, max 230 mL/total dose

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined

hepatic dosing

[see below]
hepatic impairment: not defined, caution advised in hepatorenal disease

Peds Dosing .

Dosage forms:  INJ: 200 mg per mL, 250 mg per mL, 300 mg per mL, 370 mg per mL

Special Note

[strength clarification]
Info: strength expressed as iodine concentration
[equivalency or interchangeability info]
Info: not interchangeable with intrathecal iopamidol products; do not substitute on a mg to mg basis

angiocardiography

[neonates]
Dose: 0.5-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: cumulative dose 5 mL/kg up to 40 mL
[1-23 mo]
Dose: 0.5-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: cumulative dose 8 mL/kg up to 40 mL
[2-4 yo]
Dose: 0.5-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: cumulative dose 8 mL/kg up to 50 mL
[5-9 yo]
Dose: 0.5-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: cumulative dose 8 mL/kg up to 100 mL
[10 yo and older]
Dose: 0.5-2 mL/kg/dose (370 mg per mL) intra-arterially x1; Max: cumulative dose 8 mL/kg up to 125 mL

computed tomography

[head]
Dose: 1.2-3.6 mL/kg/dose (250 mg per mL) IV x1; Max: 120 mL/total dose; Alt: 1-3 mL/kg/dose (300 mg per mL) IV x1, max 100 mL/total dose
[body]
Dose: 1.2-3.6 mL/kg/dose (250 mg per mL) IV x1; Max: 120 mL/total dose; Alt: 1-3 mL/kg/dose (300 mg per mL) IV x1, max 100 mL/total dose
[abdomen or pelvis, <3 yo]
Dose: 50-300 mL (6 mg per mL or 9 mg per mL) PO x1; Start: 60min before procedure; Info: dilute 200 mg per mL, 250 mg per mL, 300 mg per mL, or 370 mg per mL INJ solution for PO use, see pkg insert
[abdomen or pelvis, 3-5 yo]
Dose: 300-360 mL (6 mg per mL or 9 mg per mL) PO x1; Start: 60min before procedure; Info: dilute 200 mg per mL, 250 mg per mL, 300 mg per mL, or 370 mg per mL INJ solution for PO use, see pkg insert
[abdomen or pelvis, 6-11 yo]
Dose: 360-500 mL (6 mg per mL or 9 mg per mL) PO x1; Start: 60min before procedure; Info: dilute 200 mg per mL, 250 mg per mL, 300 mg per mL, or 370 mg per mL INJ solution for PO use, see pkg insert
[abdomen or pelvis, 12 yo and older]
Dose: 500-1000 mL (6 mg per mL or 9 mg per mL) PO x1; Start: 60min before procedure; Info: dilute 200 mg per mL, 250 mg per mL, 300 mg per mL, or 370 mg per mL INJ solution for PO use, see pkg insert

excretory urography

[1.2-3.6 mL/kg/dose (250 mg per mL) IV x1]
Max: 120 mL/total dose; Alt: 1-3 mL/kg/dose (300 mg per mL) IV x1, max 100 mL/total dose

renal dosing

[see below]
renal impairment: not defined, caution advised
HD/PD: not defined

hepatic dosing

[not defined]
hepatic impairment: not defined, caution advised in hepatorenal disease

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@2eff09b5
  • intrathecal use
  • homocystinuria (angiography use)
  • hypersensitivity to drug or ingredient
  • caution: patients <3 yo
  • caution: hypersensitivity to other iodinated contrast media
  • caution: asthma
  • caution: allergies, known
  • caution: renal impairment
  • caution: renal impairment risk
  • caution: arterial disease, severe
  • caution: venous disease, severe
  • caution: hyperthyroidism
  • caution: autonomously functioning thyroid nodule
  • caution: cardiovascular disease
  • caution: CHF
  • caution: hepatorenal disease
  • caution: cardiorenal disease
  • caution: congenital cardiac conditions (peds patients)
  • caution: thromboembolism risk (angiography use)
  • caution: pheochromocytoma
  • caution: myasthenia gravis

Drug Interactions .

Overview

iopamidol

contrast agent

Interaction Characteristics:
  • lowers seizure threshold
  • nephrotoxicity
  • thrombogenic effects
Other Info
  • avoid radioactive iodine during and up to 6wk after iopamidol tx; iopamidol may decr. thyroid uptake of radioactive iodine, efficacy

Contraindicated

  • betamethasone
  • Isovue (iopamidol)
    +
    betamethasone
    1 interaction

    Contraindicated

    iopamidol + betamethasone

    contraindicated if intrathecal iopamidol use and intrathecal betamethasone use; otherwise, caution advised if intrathecal iopamidol use, consider holding betamethasone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cidofovir
  • Isovue (iopamidol)
    +
    cidofovir
    1 interaction

    Contraindicated

    iopamidol + cidofovir

    contraindicated; D/C IV iopamidol use at least 7 days prior to cidofovir tx: combo may incr. cidofovir levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • dexamethasone
  • Isovue (iopamidol)
    +
    dexamethasone
    1 interaction

    Contraindicated

    iopamidol + dexamethasone

    contraindicated if intrathecal iopamidol use and intrathecal dexamethasone use; otherwise, caution advised if intrathecal iopamidol use, consider holding dexamethasone at least 48h before and at least 24h after intrathecal iopamidol; monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of seizures, thromboembolism (additive effects)

  • hydrocortisone
  • Isovue (iopamidol)
    +
    hydrocortisone
    1 interaction

    Contraindicated

    iopamidol + hydrocortisone

    contraindicated if intrathecal iopamidol use and intrathecal hydrocortisone use; otherwise, caution advised if intrathecal iopamidol use, consider holding hydrocortisone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • methylprednisolone
  • Isovue (iopamidol)
    +
    methylprednisolone
    1 interaction

    Contraindicated

    iopamidol + methylprednisolone

    contraindicated if intrathecal iopamidol use and intrathecal methylprednisolone use; otherwise, caution advised if intrathecal iopamidol use, consider holding methylprednisolone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

Avoid/Use Alternative

  • aldesleukin
  • Isovue (iopamidol)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    iopamidol + aldesleukin

    avoid combo; caution advised for several months after aldesleukin tx: combo may incr. risk of nephrotoxicity, seizures; may incr. risk of delayed adverse reactions (additive effects; mechanism unknown)

  • amifampridine
  • Isovue (iopamidol)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    iopamidol + amifampridine

    consider alternative if intrathecal iopamidol use; otherwise, consider holding amifampridine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amikacin
  • Isovue (iopamidol)
    +
    amikacin
    1 interaction

    Avoid/Use Alternative

    iopamidol + amikacin

    use alternative or monitor amikacin levels, renal fxn, ototoxicity if IV iopamidol use: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • amikacin inhaled
  • Isovue (iopamidol)
    +
    amikacin inhaled
    1 interaction

    Avoid/Use Alternative

    iopamidol + amikacin inhaled

    use alternative or monitor renal fxn, ototoxicity if IV iopamidol use: combo may incr. amikacin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • bumetanide
  • Isovue (iopamidol)
    +
    bumetanide
    1 interaction

    Avoid/Use Alternative

    iopamidol + bumetanide

    if IV iopamidol use, use alternative or monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clofarabine
  • Isovue (iopamidol)
    +
    clofarabine
    1 interaction

    Avoid/Use Alternative

    iopamidol + clofarabine

    avoid IV iopamidol use during 5 day clofarabine tx; monitor CBC, renal fxn, BP: combo may incr. clofarabine levels, risk of serious infection, myelosuppression, nephrotoxicity, hypotension, other adverse effects (additive effects)

  • foscarnet
  • Isovue (iopamidol)
    +
    foscarnet
    1 interaction

    Avoid/Use Alternative

    iopamidol + foscarnet

    use alternative or monitor CBC, renal fxn if IV iopamidol use; caution advised if intrathecal iopamidol use; consider holding foscarnet at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. foscarnet levels, risk of myelosuppression, nephrotoxicity, seizures, other adverse effects (additive effects)

  • ganciclovir
  • Isovue (iopamidol)
    +
    ganciclovir
    1 interaction

    Avoid/Use Alternative

    iopamidol + ganciclovir

    use alternative or monitor CBC, renal fxn if IV iopamidol use; caution advised if intrathecal iopamidol use; consider holding ganciclovir at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, seizures, other adverse effects (additive effects)

  • gentamicin
  • Isovue (iopamidol)
    +
    gentamicin
    1 interaction

    Avoid/Use Alternative

    iopamidol + gentamicin

    use alternative or monitor gentamicin levels, renal fxn, ototoxicity if IV iopamidol use: combo may incr. gentamicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • iodixanol
  • Isovue (iopamidol)
    +
    iodixanol
    1 interaction

    Avoid/Use Alternative

    iopamidol + iodixanol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iohexol
  • Isovue (iopamidol)
    +
    iohexol
    1 interaction

    Avoid/Use Alternative

    iopamidol + iohexol

    avoid combo: combo may incr. risk of nephrotoxicity, thromboembolism, seizures, other adverse effects (additive effects, duplicate therapy)

  • iomeprol
  • Isovue (iopamidol)
    +
    iomeprol
    1 interaction

    Avoid/Use Alternative

    iopamidol + iomeprol

    avoid combo: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iopamidol
  • Isovue (iopamidol)
    +
    iopamidol
    1 interaction

    Avoid/Use Alternative

    iopamidol + iopamidol

    avoid combo: combo may incr. risk of nephrotoxicity, thromboembolism, seizures, other adverse effects (additive effects, duplicate therapy)

  • iopromide
  • Isovue (iopamidol)
    +
    iopromide
    1 interaction

    Avoid/Use Alternative

    iopamidol + iopromide

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • iothalamate meglumine
  • Isovue (iopamidol)
    +
    iothalamate meglumine
    1 interaction

    Avoid/Use Alternative

    iopamidol + iothalamate meglumine

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • ioversol
  • Isovue (iopamidol)
    +
    ioversol
    1 interaction

    Avoid/Use Alternative

    iopamidol + ioversol

    use alternative or monitor renal function, thrombosis signs/symptoms: combo may incr. risk of nephrotoxicity, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • mannitol
  • Isovue (iopamidol)
    +
    mannitol
    1 interaction

    Avoid/Use Alternative

    iopamidol + mannitol

    if IV iopamidol use, use alternative or monitor renal fxn: combo may incr. mannitol levels, risk of nephrotoxicity, neurotoxicity (including life-threatening), other adverse effects (additive effects)

  • oxaliplatin
  • Isovue (iopamidol)
    +
    oxaliplatin
    1 interaction

    Avoid/Use Alternative

    iopamidol + oxaliplatin

    use alternative or monitor ECG, CBC, renal fxn, ototoxicity if IV iopamidol use: combo may incr. oxaliplatin levels, risk of QT prolongation, cardiac arrhythmias, serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • pentamidine
  • Isovue (iopamidol)
    +
    pentamidine
    1 interaction

    Avoid/Use Alternative

    iopamidol + pentamidine

    use alternative or monitor renal fxn if IV iopamidol use: combo may incr. risk of nephrotoxicity (additive effects)

  • polymyxin B
  • Isovue (iopamidol)
    +
    polymyxin B
    1 interaction

    Avoid/Use Alternative

    iopamidol + polymyxin B

    if IV iopamidol use, avoid combo: combo may incr. risk of nephrotoxicity (additive effects)

  • streptomycin
  • Isovue (iopamidol)
    +
    streptomycin
    1 interaction

    Avoid/Use Alternative

    iopamidol + streptomycin

    use alternative or monitor renal fxn, ototoxicity if IV iopamidol use: combo may incr. streptomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • streptozocin
  • Isovue (iopamidol)
    +
    streptozocin
    1 interaction

    Avoid/Use Alternative

    iopamidol + streptozocin

    use alternative or monitor renal fxn if IV iopamidol use: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir disoproxil
  • Isovue (iopamidol)
    +
    tenofovir disoproxil
    1 interaction

    Avoid/Use Alternative

    iopamidol + tenofovir disoproxil

    use alternative or monitor renal fxn if IV iopamidol use: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • tobramycin
  • Isovue (iopamidol)
    +
    tobramycin
    1 interaction

    Avoid/Use Alternative

    iopamidol + tobramycin

    use alternative or monitor tobramycin levels, renal fxn, ototoxicity if IV iopamidol use: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tobramycin inhaled
  • Isovue (iopamidol)
    +
    tobramycin inhaled
    1 interaction

    Avoid/Use Alternative

    iopamidol + tobramycin inhaled

    use alternative or monitor renal fxn, ototoxicity if IV iopamidol use: combo may incr. tobramycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • tranexamic acid
  • Isovue (iopamidol)
    +
    tranexamic acid
    1 interaction

    Avoid/Use Alternative

    iopamidol + tranexamic acid

    if IV iopamidol use, avoid combo; caution advised if intrathecal iopamidol use; consider holding tranexamic acid at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures, thromboembolism (additive effects)

  • vaccinia immune globulin
  • Isovue (iopamidol)
    +
    vaccinia immune globulin
    1 interaction

    Avoid/Use Alternative

    iopamidol + vaccinia immune globulin

    if IV iopamidol use, use alternative or monitor renal fxn, thrombosis s/sx; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • valganciclovir
  • Isovue (iopamidol)
    +
    valganciclovir
    1 interaction

    Avoid/Use Alternative

    iopamidol + valganciclovir

    use alternative or monitor CBC, renal fxn if IV iopamidol use; caution advised if intrathecal iopamidol use; consider holding valganciclovir at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. ganciclovir levels, risk of myelosuppression, nephrotoxicity, seizures, other adverse effects (additive effects)

Monitor/Modify Tx

  • abemaciclib
  • Isovue (iopamidol)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    iopamidol + abemaciclib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • abrocitinib
  • Isovue (iopamidol)
    +
    abrocitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + abrocitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • acyclovir
  • Isovue (iopamidol)
    +
    acyclovir
    1 interaction

    Monitor/Modify Tx

    iopamidol + acyclovir

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use; consider holding acyclovir at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. acyclovir levels, risk of nephrotoxicity, seizures, other adverse effects (additive effects)

  • adefovir dipivoxil
  • Isovue (iopamidol)
    +
    adefovir dipivoxil
    1 interaction

    Monitor/Modify Tx

    iopamidol + adefovir dipivoxil

    if IV iopamidol use, monitor renal fxn: combo may incr. adefovir levels, risk of nephrotoxicity, other adverse effects (renal excretion decreased by nephrotoxic agents, additive effects)

  • aflibercept
  • Isovue (iopamidol)
    +
    aflibercept
    1 interaction

    Monitor/Modify Tx

    iopamidol + aflibercept

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • alectinib
  • Isovue (iopamidol)
    +
    alectinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + alectinib

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • alfentanil
  • Isovue (iopamidol)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    iopamidol + alfentanil

    caution advised if intrathecal iopamidol use; consider holding alfentanil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • aliskiren
  • Isovue (iopamidol)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    iopamidol + aliskiren

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • amiloride
  • Isovue (iopamidol)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    iopamidol + amiloride

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • aminocaproic acid
  • Isovue (iopamidol)
    +
    aminocaproic acid
    1 interaction

    Monitor/Modify Tx

    iopamidol + aminocaproic acid

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • aminophylline
  • Isovue (iopamidol)
    +
    aminophylline
    1 interaction

    Monitor/Modify Tx

    iopamidol + aminophylline

    caution advised if intrathecal iopamidol use; consider holding aminophylline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amitriptyline
  • Isovue (iopamidol)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    iopamidol + amitriptyline

    caution advised if intrathecal iopamidol use; consider holding amitriptyline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amoxapine
  • Isovue (iopamidol)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + amoxapine

    caution advised if intrathecal iopamidol use; consider holding amoxapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amoxicillin
  • Isovue (iopamidol)
    +
    amoxicillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + amoxicillin

    caution advised if intrathecal iopamidol use, especially w/ high amoxicillin doses or concomitant renal impairment; consider holding amoxicillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amphetamine
  • Isovue (iopamidol)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + amphetamine

    caution advised if intrathecal iopamidol use; consider holding amphetamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • amphotericin
  • Isovue (iopamidol)
    +
    amphotericin
    1 interaction

    Monitor/Modify Tx

    iopamidol + amphotericin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ampicillin
  • Isovue (iopamidol)
    +
    ampicillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + ampicillin

    caution advised if intrathecal iopamidol use, especially w/ high ampicillin doses or concomitant renal impairment; consider holding ampicillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • angiotensin II
  • Isovue (iopamidol)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    iopamidol + angiotensin II

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • anthrax immune globulin
  • Isovue (iopamidol)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + anthrax immune globulin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • anti-inhibitor coagulant complex
  • Isovue (iopamidol)
    +
    anti-inhibitor coagulant complex
    1 interaction

    Monitor/Modify Tx

    iopamidol + anti-inhibitor coagulant complex

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • Isovue (iopamidol)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    1 interaction

    Monitor/Modify Tx

    iopamidol + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • apalutamide
  • Isovue (iopamidol)
    +
    apalutamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + apalutamide

    caution advised if intrathecal iopamidol use; consider holding apalutamide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • aripiprazole bimonthly injection
  • Isovue (iopamidol)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    iopamidol + aripiprazole bimonthly injection

    caution advised if intrathecal iopamidol use; consider holding aripiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • aripiprazole lauroxil
  • Isovue (iopamidol)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    iopamidol + aripiprazole lauroxil

    caution advised if intrathecal iopamidol use; consider holding aripiprazole lauroxil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • aripiprazole monthly injection
  • Isovue (iopamidol)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    iopamidol + aripiprazole monthly injection

    caution advised if intrathecal iopamidol use; consider holding aripiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • aripiprazole oral
  • Isovue (iopamidol)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    iopamidol + aripiprazole oral

    caution advised if intrathecal iopamidol use; consider holding aripiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • asciminib
  • Isovue (iopamidol)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    iopamidol + asciminib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • asenapine
  • Isovue (iopamidol)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + asenapine

    caution advised if intrathecal iopamidol use; consider holding asenapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • asparaginase
  • Isovue (iopamidol)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    iopamidol + asparaginase

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • aspirin
  • Isovue (iopamidol)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    iopamidol + aspirin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • atidarsagene autotemcel
  • Isovue (iopamidol)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    iopamidol + atidarsagene autotemcel

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • auranofin
  • Isovue (iopamidol)
    +
    auranofin
    1 interaction

    Monitor/Modify Tx

    iopamidol + auranofin

    if IV iopamidol use, monitor renal fxn: combo may incr. auranofin levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • avatrombopag
  • Isovue (iopamidol)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    iopamidol + avatrombopag

    if IV iopamidol use, monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • axicabtagene ciloleucel
  • Isovue (iopamidol)
    +
    axicabtagene ciloleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + axicabtagene ciloleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • axitinib
  • Isovue (iopamidol)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + axitinib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • azilsartan medoxomil
  • Isovue (iopamidol)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    iopamidol + azilsartan medoxomil

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • baclofen
  • Isovue (iopamidol)
    +
    baclofen
    1 interaction

    Monitor/Modify Tx

    iopamidol + baclofen

    caution advised if intrathecal iopamidol use; consider holding baclofen at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • baclofen intrathecal
  • Isovue (iopamidol)
    +
    baclofen intrathecal
    1 interaction

    Monitor/Modify Tx

    iopamidol + baclofen intrathecal

    caution advised if intrathecal iopamidol use; consider holding baclofen intrathecal at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • balsalazide
  • Isovue (iopamidol)
    +
    balsalazide
    1 interaction

    Monitor/Modify Tx

    iopamidol + balsalazide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • baricitinib
  • Isovue (iopamidol)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + baricitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bazedoxifene
  • Isovue (iopamidol)
    +
    bazedoxifene
    1 interaction

    Monitor/Modify Tx

    iopamidol + bazedoxifene

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • benazepril
  • Isovue (iopamidol)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    iopamidol + benazepril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • benzphetamine
  • Isovue (iopamidol)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + benzphetamine

    caution advised if intrathecal iopamidol use; consider holding benzphetamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • bevacizumab
  • Isovue (iopamidol)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + bevacizumab

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • binimetinib
  • Isovue (iopamidol)
    +
    binimetinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + binimetinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bleomycin
  • Isovue (iopamidol)
    +
    bleomycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + bleomycin

    if IV iopamidol use, monitor renal fxn; decr. bleomycin dose based on CrCl: combo may incr. bleomycin levels, risk of pulmonary toxicities (including life-threatening), other adverse effects (renal excretion decreased)

  • botulism immune globulin
  • Isovue (iopamidol)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + botulism immune globulin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest botulism immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • brexpiprazole
  • Isovue (iopamidol)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    iopamidol + brexpiprazole

    caution advised if intrathecal iopamidol use; consider holding brexpiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • brexucabtagene autoleucel
  • Isovue (iopamidol)
    +
    brexucabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + brexucabtagene autoleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • brolucizumab
  • Isovue (iopamidol)
    +
    brolucizumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + brolucizumab

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • buprenorphine
  • Isovue (iopamidol)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    iopamidol + buprenorphine

    caution advised if intrathecal iopamidol use; consider holding buprenorphine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • bupropion
  • Isovue (iopamidol)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    iopamidol + bupropion

    caution advised if intrathecal iopamidol use; consider holding bupropion at least 48h before and at least 24h after intrathecal iopamidol; consider lower bupropion doses: combo may incr. risk of seizures (additive effects)

  • busulfan
  • Isovue (iopamidol)
    +
    busulfan
    1 interaction

    Monitor/Modify Tx

    iopamidol + busulfan

    caution advised if intrathecal iopamidol use; consider holding busulfan at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • butorphanol
  • Isovue (iopamidol)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    iopamidol + butorphanol

    caution advised if intrathecal iopamidol use; consider holding butorphanol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • C1 esterase inhibitor
  • Isovue (iopamidol)
    +
    C1 esterase inhibitor
    1 interaction

    Monitor/Modify Tx

    iopamidol + C1 esterase inhibitor

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cabozantinib
  • Isovue (iopamidol)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + cabozantinib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • calaspargase
  • Isovue (iopamidol)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    iopamidol + calaspargase

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • candesartan cilexetil
  • Isovue (iopamidol)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    iopamidol + candesartan cilexetil

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • capecitabine
  • Isovue (iopamidol)
    +
    capecitabine
    1 interaction

    Monitor/Modify Tx

    iopamidol + capecitabine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • captopril
  • Isovue (iopamidol)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    iopamidol + captopril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • carboplatin
  • Isovue (iopamidol)
    +
    carboplatin
    1 interaction

    Monitor/Modify Tx

    iopamidol + carboplatin

    if IV iopamidol use, monitor CBC, renal fxn, ototoxicity: combo may incr. carboplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • carfilzomib
  • Isovue (iopamidol)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    iopamidol + carfilzomib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • cariprazine
  • Isovue (iopamidol)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + cariprazine

    caution advised if intrathecal iopamidol use; consider holding cariprazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cefazolin
  • Isovue (iopamidol)
    +
    cefazolin
    1 interaction

    Monitor/Modify Tx

    iopamidol + cefazolin

    caution advised if intrathecal iopamidol use, especially w/ high cefazolin doses and/or concomitant renal impairment; consider holding cefazolin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cefepime
  • Isovue (iopamidol)
    +
    cefepime
    1 interaction

    Monitor/Modify Tx

    iopamidol + cefepime

    caution advised if intrathecal iopamidol use, especially w/ high cefepime doses and/or concomitant renal impairment; consider holding cefepime at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cefiderocol
  • Isovue (iopamidol)
    +
    cefiderocol
    1 interaction

    Monitor/Modify Tx

    iopamidol + cefiderocol

    caution advised if intrathecal iopamidol use, especially w/ high cefiderocol doses and/or concomitant renal impairment; consider holding cefiderocol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ceftaroline
  • Isovue (iopamidol)
    +
    ceftaroline
    1 interaction

    Monitor/Modify Tx

    iopamidol + ceftaroline

    caution advised if intrathecal iopamidol use, especially w/ high ceftaroline doses and/or concomitant renal impairment; consider holding ceftaroline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ceftazidime
  • Isovue (iopamidol)
    +
    ceftazidime
    1 interaction

    Monitor/Modify Tx

    iopamidol + ceftazidime

    caution advised if intrathecal iopamidol use, especially w/ high ceftazidime doses and/or concomitant renal impairment; consider holding ceftazidime at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ceftobiprole
  • Isovue (iopamidol)
    +
    ceftobiprole
    1 interaction

    Monitor/Modify Tx

    iopamidol + ceftobiprole

    caution advised if intrathecal iopamidol use; consider holding ceftobiprole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • celecoxib
  • Isovue (iopamidol)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    iopamidol + celecoxib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • chlorambucil
  • Isovue (iopamidol)
    +
    chlorambucil
    1 interaction

    Monitor/Modify Tx

    iopamidol + chlorambucil

    caution advised if intrathecal iopamidol use; consider holding chlorambucil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • chloroquine
  • Isovue (iopamidol)
    +
    chloroquine
    1 interaction

    Monitor/Modify Tx

    iopamidol + chloroquine

    caution advised if intrathecal iopamidol use; consider holding chloroquine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • chlorothiazide
  • Isovue (iopamidol)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    iopamidol + chlorothiazide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • chlorpromazine
  • Isovue (iopamidol)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + chlorpromazine

    caution advised if intrathecal iopamidol use; consider holding chlorpromazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • chlorthalidone
  • Isovue (iopamidol)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + chlorthalidone

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • chorionic gonadotropin
  • Isovue (iopamidol)
    +
    chorionic gonadotropin
    1 interaction

    Monitor/Modify Tx

    iopamidol + chorionic gonadotropin

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ciltacabtagene autoleucel
  • Isovue (iopamidol)
    +
    ciltacabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + ciltacabtagene autoleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • ciprofloxacin
  • Isovue (iopamidol)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + ciprofloxacin

    caution advised if intrathecal iopamidol use; consider holding ciprofloxacin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cisatracurium
  • Isovue (iopamidol)
    +
    cisatracurium
    1 interaction

    Monitor/Modify Tx

    iopamidol + cisatracurium

    caution advised if intrathecal iopamidol use; consider holding cisatracurium at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cisplatin
  • Isovue (iopamidol)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    iopamidol + cisplatin

    if IV iopamidol use, monitor CBC, renal fxn, ototoxicity: combo may incr. cisplatin levels, risk of serious infection, myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • citalopram
  • Isovue (iopamidol)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    iopamidol + citalopram

    caution advised if intrathecal iopamidol use; consider holding citalopram at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • clindamycin
  • Isovue (iopamidol)
    +
    clindamycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + clindamycin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • clomipramine
  • Isovue (iopamidol)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    iopamidol + clomipramine

    caution advised if intrathecal iopamidol use; consider holding clomipramine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • clozapine
  • Isovue (iopamidol)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + clozapine

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding clozapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • coagulation factor IX
  • Isovue (iopamidol)
    +
    coagulation factor IX
    1 interaction

    Monitor/Modify Tx

    iopamidol + coagulation factor IX

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • Isovue (iopamidol)
    +
    coagulation factor VIIa
    1 interaction

    Monitor/Modify Tx

    iopamidol + coagulation factor VIIa

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • Isovue (iopamidol)
    +
    coagulation factor XIII A-subunit
    1 interaction

    Monitor/Modify Tx

    iopamidol + coagulation factor XIII A-subunit

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cocaine
  • Isovue (iopamidol)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    iopamidol + cocaine

    caution advised if intrathecal iopamidol use; consider holding cocaine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • codeine
  • Isovue (iopamidol)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    iopamidol + codeine

    caution advised if intrathecal iopamidol use; consider holding codeine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • colistimethate
  • Isovue (iopamidol)
    +
    colistimethate
    1 interaction

    Monitor/Modify Tx

    iopamidol + colistimethate

    if IV iopamidol use, monitor renal fxn: combo may incr. colistimethate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • concizumab
  • Isovue (iopamidol)
    +
    concizumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + concizumab

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • copper histidinate
  • Isovue (iopamidol)
    +
    copper histidinate
    1 interaction

    Monitor/Modify Tx

    iopamidol + copper histidinate

    if IV iopamidol use, monitor renal fxn, electrolytes: combo may incr. risk of nephrotoxicity (additive effects)

  • cortisone
  • Isovue (iopamidol)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    iopamidol + cortisone

    caution advised if intrathecal iopamidol use; consider holding cortisone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • creatine
  • Isovue (iopamidol)
    +
    creatine
    1 interaction

    Monitor/Modify Tx

    iopamidol + creatine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • cyclobenzaprine
  • Isovue (iopamidol)
    +
    cyclobenzaprine
    1 interaction

    Monitor/Modify Tx

    iopamidol + cyclobenzaprine

    caution advised if intrathecal iopamidol use; consider holding cyclobenzaprine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • cyclophosphamide
  • Isovue (iopamidol)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + cyclophosphamide

    if IV iopamidol use, monitor CBC, renal, cardiac fxn: combo may incr. cyclophosphamide levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (additive effects)

  • cyclosporine
  • Isovue (iopamidol)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    iopamidol + cyclosporine

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use; consider holding cyclosporine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • cytomegalovirus immune globulin
  • Isovue (iopamidol)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + cytomegalovirus immune globulin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest cytomegalovirus immune globulin concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • dalfampridine
  • Isovue (iopamidol)
    +
    dalfampridine
    1 interaction

    Monitor/Modify Tx

    iopamidol + dalfampridine

    caution advised if intrathecal iopamidol use; consider holding dalfampridine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • danazol
  • Isovue (iopamidol)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    iopamidol + danazol

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • darbepoetin alfa
  • Isovue (iopamidol)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    iopamidol + darbepoetin alfa

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding darbepoetin alfa at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • darolutamide
  • Isovue (iopamidol)
    +
    darolutamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + darolutamide

    caution advised if intrathecal iopamidol use; consider holding darolutamide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • deferasirox
  • Isovue (iopamidol)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    iopamidol + deferasirox

    if IV iopamidol use, monitor CBC, renal fxn, ototoxicity: combo may incr. deferasirox levels, risk of myelosuppression, nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • deferoxamine
  • Isovue (iopamidol)
    +
    deferoxamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + deferoxamine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • deflazacort
  • Isovue (iopamidol)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    iopamidol + deflazacort

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding deflazacort at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • delafloxacin
  • Isovue (iopamidol)
    +
    delafloxacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + delafloxacin

    caution advised if intrathecal iopamidol use; consider holding delafloxacin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • desipramine
  • Isovue (iopamidol)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    iopamidol + desipramine

    caution advised if intrathecal iopamidol use; consider holding desipramine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • desogestrel (contraceptive)
  • Isovue (iopamidol)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + desogestrel (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • desvenlafaxine
  • Isovue (iopamidol)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    iopamidol + desvenlafaxine

    caution advised if intrathecal iopamidol use; consider holding desvenlafaxine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • deuruxolitinib
  • Isovue (iopamidol)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + deuruxolitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dexmethylphenidate
  • Isovue (iopamidol)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    iopamidol + dexmethylphenidate

    caution advised if intrathecal iopamidol use; consider holding dexmethylphenidate at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • dextroamphetamine
  • Isovue (iopamidol)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + dextroamphetamine

    caution advised if intrathecal iopamidol use; consider holding dextroamphetamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • diclofenac
  • Isovue (iopamidol)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    iopamidol + diclofenac

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • diclofenac topical
  • Isovue (iopamidol)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    iopamidol + diclofenac topical

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • dicloxacillin
  • Isovue (iopamidol)
    +
    dicloxacillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + dicloxacillin

    caution advised if intrathecal iopamidol use, especially w/ high dicloxacillin doses or concomitant renal impairment; consider holding dicloxacillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • dienogest (contraceptive)
  • Isovue (iopamidol)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + dienogest (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • diethylpropion
  • Isovue (iopamidol)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    iopamidol + diethylpropion

    caution advised if intrathecal iopamidol use; consider holding diethylpropion at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • diflunisal
  • Isovue (iopamidol)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    iopamidol + diflunisal

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • dihydrocodeine
  • Isovue (iopamidol)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    iopamidol + dihydrocodeine

    caution advised if intrathecal iopamidol use; consider holding dihydrocodeine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • donepezil
  • Isovue (iopamidol)
    +
    donepezil
    1 interaction

    Monitor/Modify Tx

    iopamidol + donepezil

    caution advised if intrathecal iopamidol use; consider holding donepezil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • doxepin
  • Isovue (iopamidol)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    iopamidol + doxepin

    caution advised if intrathecal iopamidol use; consider holding doxepin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • dronabinol
  • Isovue (iopamidol)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    iopamidol + dronabinol

    caution advised if intrathecal iopamidol use; consider holding dronabinol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • drospirenone (contraceptive)
  • Isovue (iopamidol)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + drospirenone (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • drospirenone (hormone replacement)
  • Isovue (iopamidol)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + drospirenone (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • duloxetine
  • Isovue (iopamidol)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    iopamidol + duloxetine

    caution advised if intrathecal iopamidol use; consider holding duloxetine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • elinzanetant
  • Isovue (iopamidol)
    +
    elinzanetant
    1 interaction

    Monitor/Modify Tx

    iopamidol + elinzanetant

    caution advised if intrathecal iopamidol use; consider holding elinzanetant at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • elivaldogene autotemcel
  • Isovue (iopamidol)
    +
    elivaldogene autotemcel
    1 interaction

    Monitor/Modify Tx

    iopamidol + elivaldogene autotemcel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • eltrombopag
  • Isovue (iopamidol)
    +
    eltrombopag
    1 interaction

    Monitor/Modify Tx

    iopamidol + eltrombopag

    if IV iopamidol use, monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • enalapril
  • Isovue (iopamidol)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    iopamidol + enalapril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • enalaprilat
  • Isovue (iopamidol)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    iopamidol + enalaprilat

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • enzalutamide
  • Isovue (iopamidol)
    +
    enzalutamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + enzalutamide

    caution advised if intrathecal iopamidol use; consider holding enzalutamide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ephedra
  • Isovue (iopamidol)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    iopamidol + ephedra

    caution advised if intrathecal iopamidol use; consider holding ephedra at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • epirubicin
  • Isovue (iopamidol)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    iopamidol + epirubicin

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • epoetin alfa
  • Isovue (iopamidol)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    iopamidol + epoetin alfa

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding epoetin alfa at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • ertapenem
  • Isovue (iopamidol)
    +
    ertapenem
    1 interaction

    Monitor/Modify Tx

    iopamidol + ertapenem

    caution advised if intrathecal iopamidol use; consider holding ertapenem at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • escitalopram
  • Isovue (iopamidol)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    iopamidol + escitalopram

    caution advised if intrathecal iopamidol use; consider holding escitalopram at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • estetrol (contraceptive)
  • Isovue (iopamidol)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + estetrol (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (contraceptive)
  • Isovue (iopamidol)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + estradiol (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (hormone replacement)
  • Isovue (iopamidol)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + estradiol (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, conjugated (hormone replacement)
  • Isovue (iopamidol)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + estrogens, conjugated (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, esterified (hormone replacement)
  • Isovue (iopamidol)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + estrogens, esterified (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethacrynic acid
  • Isovue (iopamidol)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    iopamidol + ethacrynic acid

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ethinyl estradiol (contraceptive)
  • Isovue (iopamidol)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + ethinyl estradiol (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethinyl estradiol (hormone replacement)
  • Isovue (iopamidol)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + ethinyl estradiol (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethynodiol (contraceptive)
  • Isovue (iopamidol)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + ethynodiol (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • etodolac
  • Isovue (iopamidol)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    iopamidol + etodolac

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • etonogestrel (contraceptive)
  • Isovue (iopamidol)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + etonogestrel (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • everolimus
  • Isovue (iopamidol)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    iopamidol + everolimus

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx, especially if immunosuppressant use: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • factor XIII concentrate
  • Isovue (iopamidol)
    +
    factor XIII concentrate
    1 interaction

    Monitor/Modify Tx

    iopamidol + factor XIII concentrate

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • Isovue (iopamidol)
    +
    faricimab
    1 interaction

    Monitor/Modify Tx

    iopamidol + faricimab

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • Isovue (iopamidol)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + fedratinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibrate
  • Isovue (iopamidol)
    +
    fenofibrate
    1 interaction

    Monitor/Modify Tx

    iopamidol + fenofibrate

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • Isovue (iopamidol)
    +
    fenofibric acid
    1 interaction

    Monitor/Modify Tx

    iopamidol + fenofibric acid

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenoprofen
  • Isovue (iopamidol)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    iopamidol + fenoprofen

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • fentanyl
  • Isovue (iopamidol)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    iopamidol + fentanyl

    caution advised if intrathecal iopamidol use; consider holding fentanyl at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • fibrinogen (human)
  • Isovue (iopamidol)
    +
    fibrinogen (human)
    1 interaction

    Monitor/Modify Tx

    iopamidol + fibrinogen (human)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fitusiran
  • Isovue (iopamidol)
    +
    fitusiran
    1 interaction

    Monitor/Modify Tx

    iopamidol + fitusiran

    if IV iopamidol use, monitor antithrombin activity level, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • flucytosine
  • Isovue (iopamidol)
    +
    flucytosine
    1 interaction

    Monitor/Modify Tx

    iopamidol + flucytosine

    if IV iopamidol use, monitor CBC, renal fxn, flucytosine levels: combo may incr. flucytosine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • fluoxetine
  • Isovue (iopamidol)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    iopamidol + fluoxetine

    caution advised if intrathecal iopamidol use; consider holding fluoxetine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • fluphenazine
  • Isovue (iopamidol)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + fluphenazine

    caution advised if intrathecal iopamidol use; consider holding fluphenazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • flurbiprofen
  • Isovue (iopamidol)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    iopamidol + flurbiprofen

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • fluvoxamine
  • Isovue (iopamidol)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + fluvoxamine

    caution advised if intrathecal iopamidol use; consider holding fluvoxamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • follitropin
  • Isovue (iopamidol)
    +
    follitropin
    1 interaction

    Monitor/Modify Tx

    iopamidol + follitropin

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fosinopril
  • Isovue (iopamidol)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    iopamidol + fosinopril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • fruquintinib
  • Isovue (iopamidol)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + fruquintinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • furosemide
  • Isovue (iopamidol)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    iopamidol + furosemide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • galantamine
  • Isovue (iopamidol)
    +
    galantamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + galantamine

    caution advised if intrathecal iopamidol use; consider holding galantamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ginkgo
  • Isovue (iopamidol)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    iopamidol + ginkgo

    if intrathecal iopamidol use, avoid consumption of ginkgo seeds; otherwise, caution advised if intrathecal iopamidol use; consider holding ginkgo at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • goserelin
  • Isovue (iopamidol)
    +
    goserelin
    1 interaction

    Monitor/Modify Tx

    iopamidol + goserelin

    caution advised if intrathecal iopamidol use; consider holding goserelin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • haloperidol
  • Isovue (iopamidol)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    iopamidol + haloperidol

    caution advised if intrathecal iopamidol use; consider holding haloperidol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • hepatitis B immune globulin
  • Isovue (iopamidol)
    +
    hepatitis B immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + hepatitis B immune globulin

    if IV iopamidol use, monitor thrombosis s/sx; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • histrelin
  • Isovue (iopamidol)
    +
    histrelin
    1 interaction

    Monitor/Modify Tx

    iopamidol + histrelin

    caution advised if intrathecal iopamidol use; consider holding histrelin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • hydrochlorothiazide
  • Isovue (iopamidol)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    iopamidol + hydrochlorothiazide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • hydrocodone
  • Isovue (iopamidol)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    iopamidol + hydrocodone

    caution advised if intrathecal iopamidol use; consider holding hydrocodone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • hydromorphone
  • Isovue (iopamidol)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    iopamidol + hydromorphone

    caution advised if intrathecal iopamidol use; consider holding hydromorphone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • hydroxocobalamin IV
  • Isovue (iopamidol)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    iopamidol + hydroxocobalamin IV

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • hydroxychloroquine
  • Isovue (iopamidol)
    +
    hydroxychloroquine
    1 interaction

    Monitor/Modify Tx

    iopamidol + hydroxychloroquine

    caution advised if intrathecal iopamidol use; consider holding hydroxychloroquine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ibuprofen
  • Isovue (iopamidol)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    iopamidol + ibuprofen

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ibuprofen lysine
  • Isovue (iopamidol)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    iopamidol + ibuprofen lysine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • idecabtagene vicleucel
  • Isovue (iopamidol)
    +
    idecabtagene vicleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + idecabtagene vicleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • ifosfamide
  • Isovue (iopamidol)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + ifosfamide

    if IV iopamidol use, monitor CBC, renal, cardiac fxn; caution advised if intrathecal iopamidol use; consider holding ifosfamide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. ifosfamide levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, seizures, other adverse effects (additive effects)

  • iloperidone
  • Isovue (iopamidol)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + iloperidone

    caution advised if intrathecal iopamidol use; consider holding iloperidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • imipenem
  • Isovue (iopamidol)
    +
    imipenem
    1 interaction

    Monitor/Modify Tx

    iopamidol + imipenem

    caution advised if intrathecal iopamidol use; consider holding imipenem at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • imipramine
  • Isovue (iopamidol)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    iopamidol + imipramine

    caution advised if intrathecal iopamidol use; consider holding imipramine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • immune globulin
  • Isovue (iopamidol)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + immune globulin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • indapamide
  • Isovue (iopamidol)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + indapamide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • indomethacin
  • Isovue (iopamidol)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + indomethacin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • interferon beta 1a
  • Isovue (iopamidol)
    +
    interferon beta 1a
    1 interaction

    Monitor/Modify Tx

    iopamidol + interferon beta 1a

    caution advised if intrathecal iopamidol use; consider holding interferon beta 1a at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • interferon beta 1b
  • Isovue (iopamidol)
    +
    interferon beta 1b
    1 interaction

    Monitor/Modify Tx

    iopamidol + interferon beta 1b

    caution advised if intrathecal iopamidol use; consider holding interferon beta 1b at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • irbesartan
  • Isovue (iopamidol)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    iopamidol + irbesartan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • isocarboxazid
  • Isovue (iopamidol)
    +
    isocarboxazid
    1 interaction

    Monitor/Modify Tx

    iopamidol + isocarboxazid

    caution advised if intrathecal iopamidol use; consider holding isocarboxazid at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • isoniazid
  • Isovue (iopamidol)
    +
    isoniazid
    1 interaction

    Monitor/Modify Tx

    iopamidol + isoniazid

    caution advised if intrathecal iopamidol use; consider holding isoniazid at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ketamine
  • Isovue (iopamidol)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + ketamine

    caution advised if intrathecal iopamidol use; consider holding ketamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ketoprofen
  • Isovue (iopamidol)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    iopamidol + ketoprofen

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ketorolac
  • Isovue (iopamidol)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    iopamidol + ketorolac

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • kratom
  • Isovue (iopamidol)
    +
    kratom
    1 interaction

    Monitor/Modify Tx

    iopamidol + kratom

    caution advised if intrathecal iopamidol use; consider holding kratom at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lazertinib
  • Isovue (iopamidol)
    +
    lazertinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + lazertinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenalidomide
  • Isovue (iopamidol)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    iopamidol + lenalidomide

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenvatinib
  • Isovue (iopamidol)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + lenvatinib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • leuprolide
  • Isovue (iopamidol)
    +
    leuprolide
    1 interaction

    Monitor/Modify Tx

    iopamidol + leuprolide

    caution advised if intrathecal iopamidol use; consider holding leuprolide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • levocarnitine
  • Isovue (iopamidol)
    +
    levocarnitine
    1 interaction

    Monitor/Modify Tx

    iopamidol + levocarnitine

    caution advised if intrathecal iopamidol use; consider holding levocarnitine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • levofloxacin
  • Isovue (iopamidol)
    +
    levofloxacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + levofloxacin

    caution advised if intrathecal iopamidol use; consider holding levofloxacin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • levomilnacipran
  • Isovue (iopamidol)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    iopamidol + levomilnacipran

    caution advised if intrathecal iopamidol use; consider holding levomilnacipran at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • levonorgestrel (contraceptive)
  • Isovue (iopamidol)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + levonorgestrel (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (hormone replacement)
  • Isovue (iopamidol)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + levonorgestrel (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • levorphanol
  • Isovue (iopamidol)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    iopamidol + levorphanol

    caution advised if intrathecal iopamidol use; consider holding levorphanol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lidocaine
  • Isovue (iopamidol)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    iopamidol + lidocaine

    caution advised if intrathecal iopamidol use; consider holding lidocaine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lidocaine topical
  • Isovue (iopamidol)
    +
    lidocaine topical
    1 interaction

    Monitor/Modify Tx

    iopamidol + lidocaine topical

    caution advised if intrathecal iopamidol use; consider holding lidocaine topical at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lifileucel
  • Isovue (iopamidol)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + lifileucel

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • linezolid
  • Isovue (iopamidol)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    iopamidol + linezolid

    caution advised if intrathecal iopamidol use; consider holding linezolid at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lisdexamfetamine
  • Isovue (iopamidol)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + lisdexamfetamine

    caution advised if intrathecal iopamidol use; consider holding lisdexamfetamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lisinopril
  • Isovue (iopamidol)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    iopamidol + lisinopril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • lisocabtagene maraleucel
  • Isovue (iopamidol)
    +
    lisocabtagene maraleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + lisocabtagene maraleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • lithium
  • Isovue (iopamidol)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    iopamidol + lithium

    if IV iopamidol use, monitor lithium levels, renal fxn; caution advised if intrathecal iopamidol use; consider holding lithium at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. lithium levels, risk of nephrotoxicity, seizures, other adverse effects (additive effects)

  • lomustine
  • Isovue (iopamidol)
    +
    lomustine
    1 interaction

    Monitor/Modify Tx

    iopamidol + lomustine

    if IV iopamidol use, monitor CBC, renal fxn: combo may incr. lomustine levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • lorlatinib
  • Isovue (iopamidol)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + lorlatinib

    caution advised if intrathecal iopamidol use; consider holding lorlatinib at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • losartan
  • Isovue (iopamidol)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    iopamidol + losartan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • loxapine
  • Isovue (iopamidol)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + loxapine

    caution advised if intrathecal iopamidol use; consider holding loxapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lumateperone
  • Isovue (iopamidol)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    iopamidol + lumateperone

    caution advised if intrathecal iopamidol use; consider holding lumateperone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • lurasidone
  • Isovue (iopamidol)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + lurasidone

    caution advised if intrathecal iopamidol use; consider holding lurasidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • luspatercept
  • Isovue (iopamidol)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    iopamidol + luspatercept

    if beta thalassemia use, monitor thrombosis s/sx w/ IV iopamidol use: combo may incr. risk of thromboembolism (additive effects)

  • lusutrombopag
  • Isovue (iopamidol)
    +
    lusutrombopag
    1 interaction

    Monitor/Modify Tx

    iopamidol + lusutrombopag

    if IV iopamidol use, monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lutetium Lu 177 vipivotide tetraxetan
  • Isovue (iopamidol)
    +
    lutetium Lu 177 vipivotide tetraxetan
    1 interaction

    Monitor/Modify Tx

    iopamidol + lutetium Lu 177 vipivotide tetraxetan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • magnesium citrate
  • Isovue (iopamidol)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    iopamidol + magnesium citrate

    if IV iopamidol use, monitor renal fxn, especially if magnesium citrate bowel prep use; caution advised if intrathecal iopamidol use, especially if magnesium citrate bowel prep use; consider holding magnesium citrate at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • magnesium salicylate
  • Isovue (iopamidol)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    iopamidol + magnesium salicylate

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • meclofenamate
  • Isovue (iopamidol)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    iopamidol + meclofenamate

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • medroxyprogesterone (contraceptive)
  • Isovue (iopamidol)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + medroxyprogesterone (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • Isovue (iopamidol)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + medroxyprogesterone (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • mefenamic acid
  • Isovue (iopamidol)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    iopamidol + mefenamic acid

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • mefloquine
  • Isovue (iopamidol)
    +
    mefloquine
    1 interaction

    Monitor/Modify Tx

    iopamidol + mefloquine

    caution advised if intrathecal iopamidol use; consider holding mefloquine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • megestrol
  • Isovue (iopamidol)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    iopamidol + megestrol

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • melatonin
  • Isovue (iopamidol)
    +
    melatonin
    1 interaction

    Monitor/Modify Tx

    iopamidol + melatonin

    caution advised if intrathecal iopamidol use; consider holding melatonin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • meloxicam
  • Isovue (iopamidol)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    iopamidol + meloxicam

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • menotropins
  • Isovue (iopamidol)
    +
    menotropins
    1 interaction

    Monitor/Modify Tx

    iopamidol + menotropins

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • meperidine
  • Isovue (iopamidol)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    iopamidol + meperidine

    caution advised if intrathecal iopamidol use; consider holding meperidine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • meropenem
  • Isovue (iopamidol)
    +
    meropenem
    1 interaction

    Monitor/Modify Tx

    iopamidol + meropenem

    caution advised if intrathecal iopamidol use; consider holding meropenem at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • mesalamine
  • Isovue (iopamidol)
    +
    mesalamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + mesalamine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • mesalamine rectal
  • Isovue (iopamidol)
    +
    mesalamine rectal
    1 interaction

    Monitor/Modify Tx

    iopamidol + mesalamine rectal

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • metformin
  • Isovue (iopamidol)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    iopamidol + metformin

    if IV iopamidol use, hold metformin if GFR 30-60 mL/min, hepatic impairment, alcoholism, and/or heart failure; may restart metformin if stable renal fxn 48h after iopamidol use: combo may incr. risk of lactic acidosis (possible additive effects)

  • methadone
  • Isovue (iopamidol)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    iopamidol + methadone

    caution advised if intrathecal iopamidol use; consider holding methadone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • methamphetamine
  • Isovue (iopamidol)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + methamphetamine

    caution advised if intrathecal iopamidol use; consider holding methamphetamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • methocarbamol
  • Isovue (iopamidol)
    +
    methocarbamol
    1 interaction

    Monitor/Modify Tx

    iopamidol + methocarbamol

    caution advised if intrathecal iopamidol use; consider holding methocarbamol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • methotrexate
  • Isovue (iopamidol)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    iopamidol + methotrexate

    if IV iopamidol use, use alternative or monitor CBC, renal fxn; caution advised if intrathecal iopamidol use; consider holding methotrexate at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Isovue (iopamidol)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    iopamidol + methoxy polyethylene glycol-epoetin beta

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding methoxy polyethylene glycol-epoetin beta at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • methyltestosterone
  • Isovue (iopamidol)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    iopamidol + methyltestosterone

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • metoclopramide
  • Isovue (iopamidol)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    iopamidol + metoclopramide

    caution advised if intrathecal iopamidol use; consider holding metoclopramide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • metolazone
  • Isovue (iopamidol)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    iopamidol + metolazone

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • metronidazole
  • Isovue (iopamidol)
    +
    metronidazole
    1 interaction

    Monitor/Modify Tx

    iopamidol + metronidazole

    caution advised if intrathecal iopamidol use; consider holding metronidazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • mexiletine
  • Isovue (iopamidol)
    +
    mexiletine
    1 interaction

    Monitor/Modify Tx

    iopamidol + mexiletine

    caution advised if intrathecal iopamidol use; consider holding mexiletine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • milnacipran
  • Isovue (iopamidol)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    iopamidol + milnacipran

    caution advised if intrathecal iopamidol use; consider holding milnacipran at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • milsaperidone
  • Isovue (iopamidol)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + milsaperidone

    caution advised if intrathecal iopamidol use; consider holding milsaperidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • mirtazapine
  • Isovue (iopamidol)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + mirtazapine

    caution advised if intrathecal iopamidol use; consider holding mirtazapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • mitomycin
  • Isovue (iopamidol)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + mitomycin

    if IV iopamidol use, monitor renal fxn; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of nephrotoxicity (additive effects)

  • moexipril
  • Isovue (iopamidol)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    iopamidol + moexipril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • molindone
  • Isovue (iopamidol)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    iopamidol + molindone

    caution advised if intrathecal iopamidol use; consider holding molindone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • momelotinib
  • Isovue (iopamidol)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + momelotinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • morphine
  • Isovue (iopamidol)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    iopamidol + morphine

    caution advised if intrathecal iopamidol use; consider holding morphine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • moxifloxacin
  • Isovue (iopamidol)
    +
    moxifloxacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + moxifloxacin

    caution advised if intrathecal iopamidol use; consider holding moxifloxacin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • nabumetone
  • Isovue (iopamidol)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    iopamidol + nabumetone

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • nafarelin nasal
  • Isovue (iopamidol)
    +
    nafarelin nasal
    1 interaction

    Monitor/Modify Tx

    iopamidol + nafarelin nasal

    caution advised if intrathecal iopamidol use; consider holding nafarelin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • nafcillin
  • Isovue (iopamidol)
    +
    nafcillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + nafcillin

    caution advised if intrathecal iopamidol use, especially w/ high nafcillin doses or concomitant renal impairment; consider holding nafcillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • nalbuphine
  • Isovue (iopamidol)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    iopamidol + nalbuphine

    caution advised if intrathecal iopamidol use; consider holding nalbuphine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • naproxen
  • Isovue (iopamidol)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    iopamidol + naproxen

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • necitumumab
  • Isovue (iopamidol)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + necitumumab

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • nefazodone
  • Isovue (iopamidol)
    +
    nefazodone
    1 interaction

    Monitor/Modify Tx

    iopamidol + nefazodone

    caution advised if intrathecal iopamidol use; consider holding nefazodone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • nelarabine
  • Isovue (iopamidol)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    iopamidol + nelarabine

    caution advised if intrathecal iopamidol use; consider holding nelarabine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • neomycin
  • Isovue (iopamidol)
    +
    neomycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + neomycin

    if compromised gut wall allows for neomycin absorption, monitor renal fxn, ototoxicity if IV iopamidol use: combo may incr. neomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • nintedanib
  • Isovue (iopamidol)
    +
    nintedanib
    1 interaction

    Monitor/Modify Tx

    iopamidol + nintedanib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norelgestromin (contraceptive)
  • Isovue (iopamidol)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + norelgestromin (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (contraceptive)
  • Isovue (iopamidol)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + norethindrone (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (hormone replacement)
  • Isovue (iopamidol)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + norethindrone (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norgestimate (contraceptive)
  • Isovue (iopamidol)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + norgestimate (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norgestrel (contraceptive)
  • Isovue (iopamidol)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + norgestrel (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • nortriptyline
  • Isovue (iopamidol)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    iopamidol + nortriptyline

    caution advised if intrathecal iopamidol use; consider holding nortriptyline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • nusinersen
  • Isovue (iopamidol)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    iopamidol + nusinersen

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • obecabtagene autoleucel
  • Isovue (iopamidol)
    +
    obecabtagene autoleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + obecabtagene autoleucel

    caution advised if intrathecal iopamidol use; consider holding obecabtagene autoleucel at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • obinutuzumab
  • Isovue (iopamidol)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + obinutuzumab

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ofloxacin
  • Isovue (iopamidol)
    +
    ofloxacin
    1 interaction

    Monitor/Modify Tx

    iopamidol + ofloxacin

    caution advised if intrathecal iopamidol use; consider holding ofloxacin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • olanzapine
  • Isovue (iopamidol)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + olanzapine

    caution advised if intrathecal iopamidol use; consider holding olanzapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • olaparib
  • Isovue (iopamidol)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    iopamidol + olaparib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • oliceridine
  • Isovue (iopamidol)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    iopamidol + oliceridine

    caution advised if intrathecal iopamidol use; consider holding oliceridine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • olmesartan medoxomil
  • Isovue (iopamidol)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    iopamidol + olmesartan medoxomil

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • olsalazine
  • Isovue (iopamidol)
    +
    olsalazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + olsalazine

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ospemifene
  • Isovue (iopamidol)
    +
    ospemifene
    1 interaction

    Monitor/Modify Tx

    iopamidol + ospemifene

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • oxacillin
  • Isovue (iopamidol)
    +
    oxacillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + oxacillin

    caution advised if intrathecal iopamidol use, especially w/ high oxacillin doses or concomitant renal impairment; consider holding oxacillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • oxaprozin
  • Isovue (iopamidol)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    iopamidol + oxaprozin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • oxycodone
  • Isovue (iopamidol)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    iopamidol + oxycodone

    caution advised if intrathecal iopamidol use; consider holding oxycodone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • oxymorphone
  • Isovue (iopamidol)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    iopamidol + oxymorphone

    caution advised if intrathecal iopamidol use; consider holding oxymorphone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pacritinib
  • Isovue (iopamidol)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + pacritinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • paliperidone
  • Isovue (iopamidol)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + paliperidone

    caution advised if intrathecal iopamidol use; consider holding paliperidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pamidronate
  • Isovue (iopamidol)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    iopamidol + pamidronate

    if IV iopamidol use, monitor renal fxn: combo may incr. pamidronate levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • paromomycin
  • Isovue (iopamidol)
    +
    paromomycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + paromomycin

    if compromised gut wall allows for paromomycin absorption, monitor renal fxn, ototoxicity if IV iopamidol use: combo may incr. paromomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • paroxetine
  • Isovue (iopamidol)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    iopamidol + paroxetine

    caution advised if intrathecal iopamidol use; consider holding paroxetine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pazopanib
  • Isovue (iopamidol)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    iopamidol + pazopanib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • pegaspargase
  • Isovue (iopamidol)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    iopamidol + pegaspargase

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • peginterferon beta 1a
  • Isovue (iopamidol)
    +
    peginterferon beta 1a
    1 interaction

    Monitor/Modify Tx

    iopamidol + peginterferon beta 1a

    caution advised if intrathecal iopamidol use; consider holding peginterferon beta 1a at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pemetrexed
  • Isovue (iopamidol)
    +
    pemetrexed
    1 interaction

    Monitor/Modify Tx

    iopamidol + pemetrexed

    if IV iopamidol use, monitor CBC, renal fxn: combo may incr. pemetrexed levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillamine
  • Isovue (iopamidol)
    +
    penicillamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + penicillamine

    if IV iopamidol use, monitor CBC, renal fxn: combo may incr. penicillamine levels, risk of myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • penicillin G
  • Isovue (iopamidol)
    +
    penicillin G
    1 interaction

    Monitor/Modify Tx

    iopamidol + penicillin G

    caution advised if intrathecal iopamidol use, especially w/ high penicillin G doses or concomitant renal impairment; consider holding penicillin G at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • penicillin V
  • Isovue (iopamidol)
    +
    penicillin V
    1 interaction

    Monitor/Modify Tx

    iopamidol + penicillin V

    caution advised if intrathecal iopamidol use, especially w/ high penicillin V doses or concomitant renal impairment; consider holding penicillin V at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pentazocine
  • Isovue (iopamidol)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    iopamidol + pentazocine

    caution advised if intrathecal iopamidol use; consider holding pentazocine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pentostatin
  • Isovue (iopamidol)
    +
    pentostatin
    1 interaction

    Monitor/Modify Tx

    iopamidol + pentostatin

    if IV iopamidol use, monitor CBC, renal fxn: combo may incr. pentostatin levels, risk of serious infection, myelosuppression, nephrotoxicity, other adverse effects (additive effects)

  • perindopril
  • Isovue (iopamidol)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    iopamidol + perindopril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • perphenazine
  • Isovue (iopamidol)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + perphenazine

    caution advised if intrathecal iopamidol use; consider holding perphenazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • phendimetrazine
  • Isovue (iopamidol)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + phendimetrazine

    caution advised if intrathecal iopamidol use; consider holding phendimetrazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • phenelzine
  • Isovue (iopamidol)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    iopamidol + phenelzine

    caution advised if intrathecal iopamidol use; consider holding phenelzine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • phentermine
  • Isovue (iopamidol)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    iopamidol + phentermine

    caution advised if intrathecal iopamidol use; consider holding phentermine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pimozide
  • Isovue (iopamidol)
    +
    pimozide
    1 interaction

    Monitor/Modify Tx

    iopamidol + pimozide

    caution advised if intrathecal iopamidol use; consider holding pimozide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • piperacillin
  • Isovue (iopamidol)
    +
    piperacillin
    1 interaction

    Monitor/Modify Tx

    iopamidol + piperacillin

    caution advised if intrathecal iopamidol use, especially w/ high piperacillin doses or concomitant renal impairment; consider holding piperacillin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • piroxicam
  • Isovue (iopamidol)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    iopamidol + piroxicam

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • plazomicin
  • Isovue (iopamidol)
    +
    plazomicin
    1 interaction

    Monitor/Modify Tx

    iopamidol + plazomicin

    if IV iopamidol use, monitor plazomicin levels, renal fxn, ototoxicity: combo may incr. plazomicin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects)

  • polyethylene glycol
  • Isovue (iopamidol)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    iopamidol + polyethylene glycol

    if IV iopamidol use, monitor renal fxn, especially if polyethylene glycol bowel prep use; caution advised if intrathecal iopamidol use, especially if polyethylene glycol bowel prep use; consider holding polyethylene glycol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Isovue (iopamidol)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    iopamidol + polyethylene glycol/ electrolytes

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use; consider holding polyethylene glycol/electrolytes at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • pomalidomide
  • Isovue (iopamidol)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    iopamidol + pomalidomide

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ponatinib
  • Isovue (iopamidol)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + ponatinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • porfimer
  • Isovue (iopamidol)
    +
    porfimer
    1 interaction

    Monitor/Modify Tx

    iopamidol + porfimer

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • prednisolone
  • Isovue (iopamidol)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    iopamidol + prednisolone

    caution advised if intrathecal iopamidol use; consider holding prednisolone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • prednisone
  • Isovue (iopamidol)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    iopamidol + prednisone

    caution advised if intrathecal iopamidol use; consider holding prednisone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • procarbazine
  • Isovue (iopamidol)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + procarbazine

    caution advised if intrathecal iopamidol use; consider holding procarbazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • prochlorperazine
  • Isovue (iopamidol)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + prochlorperazine

    caution advised if intrathecal iopamidol use; consider holding prochlorperazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • progesterone (hormone replacement)
  • Isovue (iopamidol)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + progesterone (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • Isovue (iopamidol)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    iopamidol + progesterone vaginal (hormone replacement)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • promethazine
  • Isovue (iopamidol)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + promethazine

    caution advised if intrathecal iopamidol use; consider holding promethazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • propofol
  • Isovue (iopamidol)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    iopamidol + propofol

    caution advised if intrathecal iopamidol use; consider holding propofol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • prothrombin complex concentrate (human)
  • Isovue (iopamidol)
    +
    prothrombin complex concentrate (human)
    1 interaction

    Monitor/Modify Tx

    iopamidol + prothrombin complex concentrate (human)

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • protriptyline
  • Isovue (iopamidol)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    iopamidol + protriptyline

    caution advised if intrathecal iopamidol use; consider holding protriptyline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pyridostigmine
  • Isovue (iopamidol)
    +
    pyridostigmine
    1 interaction

    Monitor/Modify Tx

    iopamidol + pyridostigmine

    caution advised if intrathecal iopamidol use; consider holding pyridostigmine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • pyrimethamine
  • Isovue (iopamidol)
    +
    pyrimethamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + pyrimethamine

    caution advised if intrathecal iopamidol use; consider holding pyrimethamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • quetiapine
  • Isovue (iopamidol)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    iopamidol + quetiapine

    caution advised if intrathecal iopamidol use; consider holding quetiapine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • quinapril
  • Isovue (iopamidol)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    iopamidol + quinapril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • quinine
  • Isovue (iopamidol)
    +
    quinine
    1 interaction

    Monitor/Modify Tx

    iopamidol + quinine

    caution advised if intrathecal iopamidol use; consider holding quinine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • raloxifene
  • Isovue (iopamidol)
    +
    raloxifene
    1 interaction

    Monitor/Modify Tx

    iopamidol + raloxifene

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ramipril
  • Isovue (iopamidol)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    iopamidol + ramipril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ramucirumab
  • Isovue (iopamidol)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + ramucirumab

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • ranibizumab
  • Isovue (iopamidol)
    +
    ranibizumab
    1 interaction

    Monitor/Modify Tx

    iopamidol + ranibizumab

    if IV iopamidol use, monitor thrombosis s/sx; risk may be lower if ocular implant use: combo may incr. risk of thromboembolism (additive effects)

  • regadenoson
  • Isovue (iopamidol)
    +
    regadenoson
    1 interaction

    Monitor/Modify Tx

    iopamidol + regadenoson

    caution advised if intrathecal iopamidol use; consider holding regadenoson at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • remifentanil
  • Isovue (iopamidol)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    iopamidol + remifentanil

    caution advised if intrathecal iopamidol use; consider holding remifentanil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • Rho(D) immune globulin
  • Isovue (iopamidol)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + Rho(D) immune globulin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • risperidone
  • Isovue (iopamidol)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + risperidone

    caution advised if intrathecal iopamidol use; consider holding risperidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ritlecitinib
  • Isovue (iopamidol)
    +
    ritlecitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + ritlecitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • rituximab
  • Isovue (iopamidol)
    +
    rituximab
    1 interaction

    Monitor/Modify Tx

    iopamidol + rituximab

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • rivastigmine
  • Isovue (iopamidol)
    +
    rivastigmine
    1 interaction

    Monitor/Modify Tx

    iopamidol + rivastigmine

    caution advised if intrathecal iopamidol use; consider holding rivastigmine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • romiplostim
  • Isovue (iopamidol)
    +
    romiplostim
    1 interaction

    Monitor/Modify Tx

    iopamidol + romiplostim

    if IV iopamidol use, monitor platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ropeginterferon alfa-2b
  • Isovue (iopamidol)
    +
    ropeginterferon alfa-2b
    1 interaction

    Monitor/Modify Tx

    iopamidol + ropeginterferon alfa-2b

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • ruxolitinib
  • Isovue (iopamidol)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + ruxolitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib topical
  • Isovue (iopamidol)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    iopamidol + ruxolitinib topical

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • salsalate
  • Isovue (iopamidol)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    iopamidol + salsalate

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • scopolamine
  • Isovue (iopamidol)
    +
    scopolamine
    1 interaction

    Monitor/Modify Tx

    iopamidol + scopolamine

    caution advised if intrathecal iopamidol use; consider holding scopolamine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • segesterone (contraceptive)
  • Isovue (iopamidol)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    iopamidol + segesterone (contraceptive)

    if IV iopamidol use, monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • selegiline transdermal
  • Isovue (iopamidol)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    iopamidol + selegiline transdermal

    caution advised if intrathecal iopamidol use; consider holding selegiline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sertraline
  • Isovue (iopamidol)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    iopamidol + sertraline

    caution advised if intrathecal iopamidol use; consider holding sertraline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sevoflurane
  • Isovue (iopamidol)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    iopamidol + sevoflurane

    caution advised if intrathecal iopamidol use; consider holding sevoflurane at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sipuleucel-T
  • Isovue (iopamidol)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    iopamidol + sipuleucel-T

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sirolimus
  • Isovue (iopamidol)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    iopamidol + sirolimus

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sitagliptin
  • Isovue (iopamidol)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    iopamidol + sitagliptin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sodium picosulfate
  • Isovue (iopamidol)
    +
    sodium picosulfate
    1 interaction

    Monitor/Modify Tx

    iopamidol + sodium picosulfate

    caution advised if intrathecal iopamidol use; consider holding sodium picosulfate at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sodium tetradecyl sulfate
  • Isovue (iopamidol)
    +
    sodium tetradecyl sulfate
    1 interaction

    Monitor/Modify Tx

    iopamidol + sodium tetradecyl sulfate

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sotatercept
  • Isovue (iopamidol)
    +
    sotatercept
    1 interaction

    Monitor/Modify Tx

    iopamidol + sotatercept

    if IV iopamidol use, monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sparsentan
  • Isovue (iopamidol)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    iopamidol + sparsentan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • spironolactone
  • Isovue (iopamidol)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    iopamidol + spironolactone

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • sufentanil
  • Isovue (iopamidol)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    iopamidol + sufentanil

    caution advised if intrathecal iopamidol use; consider holding sufentanil at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sulfate bowel prep
  • Isovue (iopamidol)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    iopamidol + sulfate bowel prep

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use; consider holding sulfate bowel prep at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of nephrotoxicity, seizures (additive effects)

  • sulindac
  • Isovue (iopamidol)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    iopamidol + sulindac

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • sumatriptan
  • Isovue (iopamidol)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    iopamidol + sumatriptan

    caution advised if intrathecal iopamidol use; consider holding sumatriptan at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • sunitinib
  • Isovue (iopamidol)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + sunitinib

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tacrolimus
  • Isovue (iopamidol)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    iopamidol + tacrolimus

    if IV iopamidol use, monitor tacrolimus levels, renal fxn; caution advised if intrathecal iopamidol use; consider holding tacrolimus at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. tacrolimus levels, risk of nephrotoxicity, seizures, other adverse effects (additive effects)

  • tamoxifen
  • Isovue (iopamidol)
    +
    tamoxifen
    1 interaction

    Monitor/Modify Tx

    iopamidol + tamoxifen

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tapentadol
  • Isovue (iopamidol)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    iopamidol + tapentadol

    caution advised if intrathecal iopamidol use; consider holding tapentadol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • teclistamab
  • Isovue (iopamidol)
    +
    teclistamab
    1 interaction

    Monitor/Modify Tx

    iopamidol + teclistamab

    caution advised if intrathecal iopamidol use; consider holding teclistamab at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • telavancin
  • Isovue (iopamidol)
    +
    telavancin
    1 interaction

    Monitor/Modify Tx

    iopamidol + telavancin

    if IV iopamidol use, monitor ECG, renal fxn: combo may incr. telavancin levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (additive effects)

  • telmisartan
  • Isovue (iopamidol)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    iopamidol + telmisartan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • temsirolimus
  • Isovue (iopamidol)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    iopamidol + temsirolimus

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tenofovir alafenamide
  • Isovue (iopamidol)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + tenofovir alafenamide

    if IV iopamidol use, monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • terbutaline
  • Isovue (iopamidol)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    iopamidol + terbutaline

    caution advised if intrathecal iopamidol use; consider holding terbutaline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • testosterone
  • Isovue (iopamidol)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    iopamidol + testosterone

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • thalidomide
  • Isovue (iopamidol)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    iopamidol + thalidomide

    if IV iopamidol use, monitor thrombosis s/sx; caution advised if intrathecal iopamidol use; consider holding thalidomide at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • theophylline
  • Isovue (iopamidol)
    +
    theophylline
    1 interaction

    Monitor/Modify Tx

    iopamidol + theophylline

    caution advised if intrathecal iopamidol use; consider holding theophylline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • thioridazine
  • Isovue (iopamidol)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + thioridazine

    caution advised if intrathecal iopamidol use; consider holding thioridazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • thiotepa
  • Isovue (iopamidol)
    +
    thiotepa
    1 interaction

    Monitor/Modify Tx

    iopamidol + thiotepa

    caution advised if intrathecal iopamidol use; consider holding thiotepa at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • thiothixene
  • Isovue (iopamidol)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    iopamidol + thiothixene

    caution advised if intrathecal iopamidol use; consider holding thiothixene at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • tinidazole
  • Isovue (iopamidol)
    +
    tinidazole
    1 interaction

    Monitor/Modify Tx

    iopamidol + tinidazole

    caution advised if intrathecal iopamidol use; consider holding tinidazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • tiopronin
  • Isovue (iopamidol)
    +
    tiopronin
    1 interaction

    Monitor/Modify Tx

    iopamidol + tiopronin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tisagenlecleucel
  • Isovue (iopamidol)
    +
    tisagenlecleucel
    1 interaction

    Monitor/Modify Tx

    iopamidol + tisagenlecleucel

    caution advised if intrathecal iopamidol use: combo may incr. risk of seizures (additive effects)

  • tivozanib
  • Isovue (iopamidol)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    iopamidol + tivozanib

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • tofacitinib
  • Isovue (iopamidol)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + tofacitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tolmetin
  • Isovue (iopamidol)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    iopamidol + tolmetin

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • toremifene
  • Isovue (iopamidol)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    iopamidol + toremifene

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • torsemide
  • Isovue (iopamidol)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    iopamidol + torsemide

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tramadol
  • Isovue (iopamidol)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    iopamidol + tramadol

    caution advised if intrathecal iopamidol use; consider holding tramadol at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • trametinib
  • Isovue (iopamidol)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + trametinib

    if IV iopamidol use, monitor thrombosis s/sx, especially in combo w/ dabrafenib: combo may incr. risk of thromboembolism (additive effects)

  • trandolapril
  • Isovue (iopamidol)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    iopamidol + trandolapril

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • tranylcypromine
  • Isovue (iopamidol)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    iopamidol + tranylcypromine

    caution advised if intrathecal iopamidol use; consider holding tranylcypromine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • tretinoin
  • Isovue (iopamidol)
    +
    tretinoin
    1 interaction

    Monitor/Modify Tx

    iopamidol + tretinoin

    if IV iopamidol use, monitor thrombosis s/sx, especially during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

  • triamcinolone
  • Isovue (iopamidol)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    iopamidol + triamcinolone

    caution advised if intrathecal iopamidol use; consider holding triamcinolone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • triamterene
  • Isovue (iopamidol)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    iopamidol + triamterene

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • trifluoperazine
  • Isovue (iopamidol)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    iopamidol + trifluoperazine

    caution advised if intrathecal iopamidol use; consider holding trifluoperazine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • trimipramine
  • Isovue (iopamidol)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    iopamidol + trimipramine

    caution advised if intrathecal iopamidol use; consider holding trimipramine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • triptorelin
  • Isovue (iopamidol)
    +
    triptorelin
    1 interaction

    Monitor/Modify Tx

    iopamidol + triptorelin

    caution advised if intrathecal iopamidol use; consider holding triptorelin at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • upadacitinib
  • Isovue (iopamidol)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    iopamidol + upadacitinib

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vadadustat
  • Isovue (iopamidol)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    iopamidol + vadadustat

    if IV iopamidol use, monitor Hgb, thrombosis s/sx; use lowest effective vadadustat dose; consider holding vadadustat at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of thromboembolism, seizures (additive effects)

  • valacyclovir
  • Isovue (iopamidol)
    +
    valacyclovir
    1 interaction

    Monitor/Modify Tx

    iopamidol + valacyclovir

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use; consider holding valacyclovir at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. acyclovir levels, risk of nephrotoxicity, seizures, other adverse effects (additive effects)

  • valoctocogene roxaparvovec
  • Isovue (iopamidol)
    +
    valoctocogene roxaparvovec
    1 interaction

    Monitor/Modify Tx

    iopamidol + valoctocogene roxaparvovec

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • valsartan
  • Isovue (iopamidol)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    iopamidol + valsartan

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • vamorolone
  • Isovue (iopamidol)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    iopamidol + vamorolone

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vancomycin
  • Isovue (iopamidol)
    +
    vancomycin
    1 interaction

    Monitor/Modify Tx

    iopamidol + vancomycin

    VANCOMYCIN IV: monitor renal fxn, vancomycin levels, ototoxicity if IV iopamidol use; VANCOMYCIN PO: consider monitoring renal fxn, vancomycin levels, ototoxicity in pts w/ severe renal impairment, severe intestinal inflammation, or prolonged course >2 g/day if IV iopamidol use: combo may incr. vancomycin levels, risk of nephrotoxicity, auditory, vestibular, other adverse effects (additive effects; incr. oral vancomycin absorption if inflamed or compromised gut mucosa)

  • varenicline
  • Isovue (iopamidol)
    +
    varenicline
    1 interaction

    Monitor/Modify Tx

    iopamidol + varenicline

    caution advised if intrathecal iopamidol use; consider holding varenicline at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • varicella zoster immune globulin
  • Isovue (iopamidol)
    +
    varicella zoster immune globulin
    1 interaction

    Monitor/Modify Tx

    iopamidol + varicella zoster immune globulin

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • venlafaxine
  • Isovue (iopamidol)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    iopamidol + venlafaxine

    caution advised if intrathecal iopamidol use; consider holding venlafaxine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • vilazodone
  • Isovue (iopamidol)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    iopamidol + vilazodone

    caution advised if intrathecal iopamidol use; consider holding vilazodone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • voclosporin
  • Isovue (iopamidol)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    iopamidol + voclosporin

    if IV iopamidol use, monitor renal fxn: combo may incr. risk of nephrotoxicity (additive effects)

  • von Willebrand factor
  • Isovue (iopamidol)
    +
    von Willebrand factor
    1 interaction

    Monitor/Modify Tx

    iopamidol + von Willebrand factor

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vorinostat
  • Isovue (iopamidol)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    iopamidol + vorinostat

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • willow bark
  • Isovue (iopamidol)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    iopamidol + willow bark

    monitor renal fxn, especially w/ high-dose willow bark: combo may incr. risk of nephrotoxicity (additive effects, willow bark may contain salicylates)

  • ziprasidone
  • Isovue (iopamidol)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    iopamidol + ziprasidone

    caution advised if intrathecal iopamidol use; consider holding ziprasidone at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • ziv-aflibercept
  • Isovue (iopamidol)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    iopamidol + ziv-aflibercept

    if IV iopamidol use, monitor renal fxn, thrombosis s/sx: combo may incr. risk of nephrotoxicity, thromboembolism (additive effects)

  • zoledronic acid
  • Isovue (iopamidol)
    +
    zoledronic acid
    1 interaction

    Monitor/Modify Tx

    iopamidol + zoledronic acid

    if IV iopamidol use, monitor renal fxn: combo may incr. zoledronic acid levels, risk of nephrotoxicity, other adverse effects (additive effects)

  • zonisamide
  • Isovue (iopamidol)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    iopamidol + zonisamide

    if IV iopamidol use, monitor renal fxn; caution advised if intrathecal iopamidol use: combo may incr. risk of nephrotoxicity; may alter seizure control (additive effects; antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • zopapogene imadenovec
  • Isovue (iopamidol)
    +
    zopapogene imadenovec
    1 interaction

    Monitor/Modify Tx

    iopamidol + zopapogene imadenovec

    if IV iopamidol use, monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

Caution Advised

  • acetazolamide
  • Isovue (iopamidol)
    +
    acetazolamide
    1 interaction

    Caution Advised

    iopamidol + acetazolamide

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • brivaracetam
  • Isovue (iopamidol)
    +
    brivaracetam
    1 interaction

    Caution Advised

    iopamidol + brivaracetam

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • cannabidiol
  • Isovue (iopamidol)
    +
    cannabidiol
    1 interaction

    Caution Advised

    iopamidol + cannabidiol

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • cannabis
  • Isovue (iopamidol)
    +
    cannabis
    1 interaction

    Caution Advised

    iopamidol + cannabis

    caution advised if intrathecal iopamidol use; consider holding cannabis at least 48h before and at least 24h after intrathecal iopamidol, especially w/ high cannabis doses: combo may incr. risk of seizures (additive effects)

  • carbamazepine
  • Isovue (iopamidol)
    +
    carbamazepine
    1 interaction

    Caution Advised

    iopamidol + carbamazepine

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • cenobamate
  • Isovue (iopamidol)
    +
    cenobamate
    1 interaction

    Caution Advised

    iopamidol + cenobamate

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • clobazam
  • Isovue (iopamidol)
    +
    clobazam
    1 interaction

    Caution Advised

    iopamidol + clobazam

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • clonazepam
  • Isovue (iopamidol)
    +
    clonazepam
    1 interaction

    Caution Advised

    iopamidol + clonazepam

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • clorazepate
  • Isovue (iopamidol)
    +
    clorazepate
    1 interaction

    Caution Advised

    iopamidol + clorazepate

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • cycloserine
  • Isovue (iopamidol)
    +
    cycloserine
    1 interaction

    Caution Advised

    iopamidol + cycloserine

    caution advised if intrathecal iopamidol use; consider holding cycloserine at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • diazepam
  • Isovue (iopamidol)
    +
    diazepam
    1 interaction

    Caution Advised

    iopamidol + diazepam

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • eslicarbazepine acetate
  • Isovue (iopamidol)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    iopamidol + eslicarbazepine acetate

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • ethosuximide
  • Isovue (iopamidol)
    +
    ethosuximide
    1 interaction

    Caution Advised

    iopamidol + ethosuximide

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • felbamate
  • Isovue (iopamidol)
    +
    felbamate
    1 interaction

    Caution Advised

    iopamidol + felbamate

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • fenfluramine
  • Isovue (iopamidol)
    +
    fenfluramine
    1 interaction

    Caution Advised

    iopamidol + fenfluramine

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • fosphenytoin
  • Isovue (iopamidol)
    +
    fosphenytoin
    1 interaction

    Caution Advised

    iopamidol + fosphenytoin

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • gabapentin
  • Isovue (iopamidol)
    +
    gabapentin
    1 interaction

    Caution Advised

    iopamidol + gabapentin

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • ganaxolone
  • Isovue (iopamidol)
    +
    ganaxolone
    1 interaction

    Caution Advised

    iopamidol + ganaxolone

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • lacosamide
  • Isovue (iopamidol)
    +
    lacosamide
    1 interaction

    Caution Advised

    iopamidol + lacosamide

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • lamotrigine
  • Isovue (iopamidol)
    +
    lamotrigine
    1 interaction

    Caution Advised

    iopamidol + lamotrigine

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • levetiracetam
  • Isovue (iopamidol)
    +
    levetiracetam
    1 interaction

    Caution Advised

    iopamidol + levetiracetam

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • lorazepam
  • Isovue (iopamidol)
    +
    lorazepam
    1 interaction

    Caution Advised

    iopamidol + lorazepam

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • methsuximide
  • Isovue (iopamidol)
    +
    methsuximide
    1 interaction

    Caution Advised

    iopamidol + methsuximide

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • midazolam
  • Isovue (iopamidol)
    +
    midazolam
    1 interaction

    Caution Advised

    iopamidol + midazolam

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • oxcarbazepine
  • Isovue (iopamidol)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    iopamidol + oxcarbazepine

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • perampanel
  • Isovue (iopamidol)
    +
    perampanel
    1 interaction

    Caution Advised

    iopamidol + perampanel

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • phenobarbital
  • Isovue (iopamidol)
    +
    phenobarbital
    1 interaction

    Caution Advised

    iopamidol + phenobarbital

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • phenytoin
  • Isovue (iopamidol)
    +
    phenytoin
    1 interaction

    Caution Advised

    iopamidol + phenytoin

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • pregabalin
  • Isovue (iopamidol)
    +
    pregabalin
    1 interaction

    Caution Advised

    iopamidol + pregabalin

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • primidone
  • Isovue (iopamidol)
    +
    primidone
    1 interaction

    Caution Advised

    iopamidol + primidone

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • rufinamide
  • Isovue (iopamidol)
    +
    rufinamide
    1 interaction

    Caution Advised

    iopamidol + rufinamide

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • stiripentol
  • Isovue (iopamidol)
    +
    stiripentol
    1 interaction

    Caution Advised

    iopamidol + stiripentol

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • tiagabine
  • Isovue (iopamidol)
    +
    tiagabine
    1 interaction

    Caution Advised

    iopamidol + tiagabine

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • topiramate
  • Isovue (iopamidol)
    +
    topiramate
    1 interaction

    Caution Advised

    iopamidol + topiramate

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • treosulfan
  • Isovue (iopamidol)
    +
    treosulfan
    1 interaction

    Caution Advised

    iopamidol + treosulfan

    caution advised if intrathecal iopamidol use; consider holding treosulfan at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • valproic acid
  • Isovue (iopamidol)
    +
    valproic acid
    1 interaction

    Caution Advised

    iopamidol + valproic acid

    caution advised w/ intrathecal iopamidol if seizure disorder use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

  • vigabatrin
  • Isovue (iopamidol)
    +
    vigabatrin
    1 interaction

    Caution Advised

    iopamidol + vigabatrin

    caution advised if intrathecal iopamidol use: combo may alter seizure control (antagonistic effects, intrathecal iopamidol may decr. seizure threshold)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@59536b3a
  • hypersensitivity reaction
  • anaphylaxis
  • cutaneous reaction, severe
  • acute kidney injury
  • hypotension
  • shock
  • cardiac arrest
  • arrhythmia
  • thromboembolism (angiography use)
  • extravasation symptoms
  • seizures
  • pulmonary edema

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@1cf078fd
  • pain

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Pregnancy/Lactation .

Pregnancy

Clinical Summary

may use during pregnancy; inadequate human data available; no known risk of fetal harm based on animal data at 1.4x and 2.7x recommended human dose

Lactation

Clinical Summary

may use while breastfeeding; no human data available, though risk of infant harm not expected based on minimal drug excretion into milk; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@5f13dc9c

Metabolism: for iopamidol: none; CYP450: none

Excretion: for iopamidol: urine primarily (100% unchanged); Half-life: 2h (intravascular route)

Subclass: Contrast Agents

Mechanism of Action
for iopamidol: attenuates X-ray beams and opacifies vessels and anatomical structures, enhancing visualization of normal and pathological tissue (nonionic iodine-based contrast medium)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Bracco Diagnostics Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@1dcb219d

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information